Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by (90)Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and...

le Pisani, Francesco, Sciuto, Rosa, Dessanti, Maria Laura, Giannarelli, Diana, Kayal, Ramy, Rea, Sandra, Marchesi, Francesco, Marino, Mirella
Foilsithe in Exp Hematol Oncol (2015)

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

le Pizzuti, Laura, Krasniqi, Eriseld, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Amodio, Antonella, Massimiani, Gioia, Pelle, Fabio, Kayal, Ramy, Vizza, Enrico, Grassadonia, Antonino, Tomao, Silverio, Venuti, Aldo, Gamucci, Teresa, Marchetti, Paolo, Natoli, Clara, Sanguineti, Giuseppe, Ciliberto, Gennaro, Vici, Patrizia
Foilsithe in J Cancer (2019)

Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS...

le Pizzuti, Laura, Krasniqi, Eriseld, Mandoj, Chiara, Marinelli, Daniele, Sergi, Domenico, Capomolla, Elisabetta, Paoletti, Giancarlo, Botti, Claudio, Kayal, Ramy, Ferranti, Francesca Romana, Sperduti, Isabella, Perracchio, Letizia, Sanguineti, Giuseppe, Marchetti, Paolo, Ciliberto, Gennaro, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Conti, Laura, Vici, Patrizia
Foilsithe in Cancers (Basel) (2020)

Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients

le Vici, Patrizia, Pizzuti, Laura, Di Lauro, Luigi, Conti, Laura, Mandoj, Chiara, Antenucci, Anna, Digiesi, Giovanna, Sergi, Domenico, Amodio, Antonella, Marchetti, Paolo, Sperati, Francesca, Valle, Mario, Garofalo, Alfredo, Vizza, Enrico, Corrado, Giacomo, Vincenzoni, Cristina, Tomao, Federica, Kayal, Ramy, Marsella, Annalise, Carosi, Mariantonia, Antoniani, Barbara, Giordano, Antonio, Maugeri-Saccà, Marcello, Barba, Maddalena
Foilsithe in J Cancer (2016)